Peyman Kabolizadeh, MD, Ph.D., Medical Director at Beaumont Health Proton Therapy Center will share the latest updates on Proton Arc Therapy on Saturday, April 27th, at 3:45 PM and on Sunday, April 28th at IBA's booth, #3500.

Motion management is another key topic in proton therapy as clinical indications continue to widen at many centers.

Marco Schwarz, MD, PhD, Head of medical physics, Proton Therapy Department Protonterapia Trento will share how to use surface imaging to monitor intrafraction target motion on Saturday, April 27th, at 10:00 AM at IBA's booth, #3500.

Sofie Gillis, Clinical Solution Director at IBA Proton Therapy, will describe treatment techniques for moving targets. A comprehensive approach to treatment of moving targets on Sunday, April 28th at 10:00 am at our IBA booth #3500.

In March 2019 IBA announced the first Flash irradiation in an IBA gantry treatment room at the University Medical Centre Groningen (UMCG) in The Netherlands. This novel technique has the potential to dramatically change the landscape of radiotherapy and patient cancer care by enhancing the therapeutic window with a fast and powerful treatment that delivers a high dose of radiation at an ultra-high dose rate. Flash irradiation also opens the door to a shift in the economics of proton therapy using hypofractionation.

Nicolas Denef, Product Management Director at IBA Proton Therapy, will make two presentations on: "Flash Therapy – A new paradigm of radiotherapy" on Saturday, April 27th and on Monday, April 29th at 1:00 PM on IBA booth #3500.

Securing the performance in Proton Therapy
After a fast installation of the Proteus®PLUS* solution by IBA, the University Medical Center Groningen (UMCG) has implemented advanced selection procedures for proton therapy in head and neck cancer patients. Preliminary results from its efforts are promising in validating the model-based approach for selecting the patients where proton therapy is the most appropriate treatment and potentially extending this approach to other indications such as breast cancer.

Anne Crijns, MD, PhD, Radiation Oncologist at UMCG, will share her experience of UMCG's model-based approach & Breast cancer program at our IBA booth #3500 on Monday, April 29th at 10:00 AM.

IBA Dosimetry developed myQA iON which enables automated dosimetry QA for data-driven Proton Therapy. myQA iON is the proprietary Patient QA software solution increasing the efficiency, accuracy, and safety of recurrent QA checks in proton therapy. It performs a sophisticated Monte Carlo dose map computation automatically in the background which saves time through task-based workflow, automation, and log file QA.

Rad Oncology Homepage